ProKidney Corp (PROK) posted a 5.84% change over the last five days signaling a new trend

On Monday, ProKidney Corp (NASDAQ: PROK) opened higher 15.60% from the last session, before settling in for the closing price of $2.82. Price fluctuations for PROK have ranged from $0.46 to $7.13 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Company’s average yearly earnings per share was noted 10.31% at the time writing. With a float of $97.12 million, this company’s outstanding shares have now reached $129.54 million.

In an organization with 204 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 100.0%, operating margin of -60453.59%, and the pretax margin is -54267.65%.

ProKidney Corp (PROK) Insider Updates

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of ProKidney Corp is 27.21%, while institutional ownership is 41.01%. The most recent insider transaction that took place on Jul 08 ’25, was worth 312,510. In this transaction Chief Regulatory Officer of this company sold 103,480 shares at a rate of $3.02, taking the stock ownership to the 0 shares. Before that another transaction happened on Jul 08 ’25, when Company’s Officer proposed sale 103,480 for $0.61, making the entire transaction worth $62,761.

ProKidney Corp (PROK) Performance Highlights and Predictions

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 10.31% per share during the next fiscal year.

ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators

Check out the current performance indicators for ProKidney Corp (PROK). In the past quarter, the stock posted a quick ratio of 10.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3078.17.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.60, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.61 in one year’s time.

Technical Analysis of ProKidney Corp (PROK)

Let’s dig in a bit further. During the last 5-days, its volume was 3.15 million. That was inferior than the volume of 5.99 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 40.24%.

During the past 100 days, ProKidney Corp’s (PROK) raw stochastic average was set at 41.98%, which indicates a significant decrease from 46.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.43 in the past 14 days, which was higher than the 0.27 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.83, while its 200-day Moving Average is $1.51.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.